A total of 13 (10%) RA patients were in remission at the baseline according to DAS28-ESR (n = 1), DAS28-CRP (n = 4), SDAI (n = 8) or CDAI (n = 4) criteria, of which 10 met one, two met two, and only one met three criteria. This evidence concerns the gene CRP and rheumatoid arthritis.